Abstract
Recent advances in tumor biology have identified the stroma as an important regulator of carcinogenesis and potentially a valuable therapeutic target. While however the fact that by targeting the stromal component of a tumor represents a potential therapeutic strategy has been established, the knowledge for specific regulators for such interactions remains poor. The latter is largely due to the fact that appropriate methodological approaches that permit the screening for such regulators are lacking. In the present review we will summarize some of the literature underlining the central role of stromal factors, and essentially that of the fibroblasts in tumorigenesis. Furthermore, we will review the experimental evidence that suggest that by interfering with tumor – stroma interactions may represent a therapeutic approach. Finally, based on various experimental evidence and theoretical considerations we will suggest a biological experimental system which might facilitate the screening of such regulators.
Keywords: Stroma, fibroblasts, screening
Current Medicinal Chemistry
Title: Regulation of Tumor-Stromal Fibroblast Interactions: Implications in Anticancer Therapy
Volume: 15 Issue: 29
Author(s): Hippokratis Kiaris, George Trimis and Athanasios G. Papavassiliou
Affiliation:
Keywords: Stroma, fibroblasts, screening
Abstract: Recent advances in tumor biology have identified the stroma as an important regulator of carcinogenesis and potentially a valuable therapeutic target. While however the fact that by targeting the stromal component of a tumor represents a potential therapeutic strategy has been established, the knowledge for specific regulators for such interactions remains poor. The latter is largely due to the fact that appropriate methodological approaches that permit the screening for such regulators are lacking. In the present review we will summarize some of the literature underlining the central role of stromal factors, and essentially that of the fibroblasts in tumorigenesis. Furthermore, we will review the experimental evidence that suggest that by interfering with tumor – stroma interactions may represent a therapeutic approach. Finally, based on various experimental evidence and theoretical considerations we will suggest a biological experimental system which might facilitate the screening of such regulators.
Export Options
About this article
Cite this article as:
Kiaris Hippokratis, Trimis George and Papavassiliou G. Athanasios, Regulation of Tumor-Stromal Fibroblast Interactions: Implications in Anticancer Therapy, Current Medicinal Chemistry 2008; 15 (29) . https://dx.doi.org/10.2174/092986708786848596
DOI https://dx.doi.org/10.2174/092986708786848596 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Effects of Nanoencapsulated Curcumin-Fe3O4 on Proliferation and hTERT Gene Expression in Lung Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Role of Epigenetics and Oxidative Stress in Gliomagenesis
CNS & Neurological Disorders - Drug Targets Mesenchymal Stem Cells for Anti-Cancer Drug Delivery
Recent Patents on Anti-Cancer Drug Discovery Subject Index To Volume 12
Current Pharmaceutical Design Recent Advances in Azo Dye Degrading Enzyme Research
Current Protein & Peptide Science Emerging Technologies for Fertility Preservation in Female Patients
Current Women`s Health Reviews The CLCA Gene Family A Novel Family of Putative Chloride Channels
Current Genomics Bypassing Cancer Resistance by Antagonizing “Inhibitor of Apoptosis Proteins” (IAPs)
Current Signal Transduction Therapy Efficacy and Cardiovascular Safety of Insulins
Current Drug Safety Cytotoxicity of Sodium Arsenite-loaded Anti-HER2 Immunoliposomes Against HER2-expressing Human Breast Cancer Cell Lines
Letters in Drug Design & Discovery Patent Selections:
Current Biomarkers (Discontinued) Molecular Bases of Liver Cancer Refractoriness to Pharmacological Treatment
Current Medicinal Chemistry Harnessing Impaired Energy Metabolism in Cancer Cell: Small Molecule- Mediated Ways to Regulate Tumorigenesis
Anti-Cancer Agents in Medicinal Chemistry Ferroquine: A New Weapon in the Fight Against Malaria
Current Medicinal Chemistry - Anti-Infective Agents Summary of Information on the Effects of Ionizing and Non-ionizing Radiation on Cytochrome P450 and Other Drug Metabolizing Enzymes and Transporters
Current Drug Metabolism Novel Conjugated Unsaturated Ketones with Submicromolar Potencies Towards some Leukemic and Colon Cancer Cells
Medicinal Chemistry Smart Nanocarriers for Targeted Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Relevance of the Neuropeptide Y System in the Biology of Cancer Progression
Current Topics in Medicinal Chemistry Synthesis, Characterization, Anti-proliferative Evaluation, and DNA Flow Cytometry Analysis of Some 2-Thiohydantoin Derivatives
Mini-Reviews in Medicinal Chemistry Current Constructs and Targets in Clinical Development for Antibody- Based Cancer Therapy
Current Drug Targets